Novel bacterial markers for pathogenic group B streptococci
US5098827A · kind A · utility
29Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 1988 |
| Grant date | Mar 24, 1992 |
| Priority date | — |
| Expiry date | Feb 26, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention concerns a novel in vitro process for identifying and quantifying native antigens on potentially pathogenic group B streptococci bacteria present in a clinical specimen. The invention process is made possible by the discovery of novel bacterial markers denoted .gamma. and .delta. epitopes which are expressed by a variety of group B streptococcal strains.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.